Subcellular distribution, molecular dynamics and catabolism of plasmalogens in myocardium

  • Linda A. Scherrer
  • Richard W. Gross
Part of the Developments in Molecular and Cellular Biochemistry book series (DMCB, volume 5)


Recent studies have implicated accelerated sarcolemmal phospholipid catabolism as a mediator of the lethal sequelae of atherosclerotic heart disease. We have demonstrated that plasmalogens are the predominant phospholipid constituents of canine myocardium and that plasmalogens are hydrolyzed by a novel calcium independent plasmalogen selective phospholipase A2. Since the activities of phospholipases are modulated by the molecular dynamics and interfacial characteristics of their phospholipid substrates, we compared the molecular dynamics of plasmenylcholine and phosphatidylcholine vesicles by electron spin resonance spectroscopy and deuterium magnetic resonance spectroscopy. Plasmenylcholine vesicles have separate and distinct molecular dynamics in comparisons to their phosphatidylcholine counterparts as ascertained by substantial decreases in the angular fluctuations and motional velocities of probes attached to their sn-2 aliphatic constituents. Furthermore, since free radical oxidation of myocardial lipid constituents occurs during myocardial ischemia and reperfusion, we demonstrated that 1O2 mediated oxidation of plasmenylcholine resulted in the generation of several products which have chromatographic characteristics and molecular masses corresponding to 2-acyl lysophosphatide derivatives. Taken together, these studies underscore the biologic significance of the predominance of sarcolemmal plasmalogens present in mammalian myocardium and suggest that their catabolism by plasmalogen selective phospholipases and/or oxidative processes may contribute to the lethal sequelae of myocardial ischemia.

Key words

sarcolemmal plasmalogens Ca2+-independent phospholipase A2 free radical-mediated oxidation of plasmenylcholine 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sobel B, Corr P, Robison A, Goldstein R, Witkowski F, Klein M: Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardium. J Clin Invest 62: 546–553, 1978PubMedCrossRefGoogle Scholar
  2. 2.
    Corr P, Snyder D, Lee B, Gross R, Keim C, Sobel B: Pathophysiological concentrations of lysophosphatides and the slow response. Am J Physiol 243: H187–H195, 1982PubMedGoogle Scholar
  3. 3.
    Chien K, Reeves J, Buja L, Bonte F, Parkey R, Willerson J: Phospholipid alterations in canine ischemic myocardium: Temporal and topographical correlations with Tc-99m PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect. Circ Res 48: 711–719, 1981PubMedGoogle Scholar
  4. 4.
    Idell-Wenger J, Grotyohann L, Neely J: Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310–4318, 1978PubMedGoogle Scholar
  5. 5.
    Hsueh W, Isakson P, Needleman P: Hormone selective lipase activation in the isolated rabbit heart. Prostaglandins 13: 1073–1091, 1977PubMedCrossRefGoogle Scholar
  6. 6.
    Liedtke A, Nellis S, Neely J: Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine. Cir Res 43: 652–661, 1978Google Scholar
  7. 7.
    Neely J, Garber D, McDonough K, Idell-Wenger J: Relationship between ventricular function and intermediates of fatty acid metabolism during myocardial ischemia: Effects of carnitine. In Ischemic myocardium and antianginal drugs, edited by M. Winbury, Y Abiko, New York, Raven Press, 1979, pp 225–234Google Scholar
  8. 8.
    Oram J, Bennetch S, Neely J: Regulation of fatty acid utilization in isolated perfused rat hearts. J Biol Chem 248: 5299–5309, 1973PubMedGoogle Scholar
  9. 9.
    Corr P, Witkowski F, Sobel B: Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest 61: 109–119, 1978PubMedCrossRefGoogle Scholar
  10. 10.
    Corr P, Snyder D, Cain M, Crafford Jr W, Gross R, Sobel B: Electrophysiological effects of amphiphiles on canine Purkinje fibers: Implications for dysrhythmia secondary to ischemia. Circ Res 49: 354–363, 1981PubMedGoogle Scholar
  11. 11.
    Clarkson C, Ten Eick R: On the mechanism of lysophosphatidylcholine-induced depolarization of cat ventricular myocardium. Circ Res 52: 543–556, 1983PubMedGoogle Scholar
  12. 12.
    Inoue D, Pappano A: L-Palmitoylcarnitine and calicum ions act similarly on excitatory ionic currents in avian ventricular muscle. Circ Res 52: 625–634, 1983PubMedGoogle Scholar
  13. 13.
    Arnsdorf M, Sawicki G: The effects of lysophosphatidyl-choline, a toxic metabolite of ischemia, on the components of cardiac excitability in sheep Purkinje fibers. Circ Res 49: 16–30, 1981PubMedGoogle Scholar
  14. 14.
    Russell D, Oliver M, Wojtczak J: Combined electrophysiological technique for assessment of the cellular basis of early ventricular arrhythmias: Experiments in dogs. Lancet 2: 686–688, 1977CrossRefGoogle Scholar
  15. 15.
    Gross R, Sobel B: Lysophosphatidylcholine metabolism in the rabbit heart. Characterization of metabolic pathways and partial purification of myocardial lysophospholipase-transacylase. J Biol Chem 257: 6702–6708, 1982PubMedGoogle Scholar
  16. 16.
    Gross R, Sobel B: Rabbit myocardial cytosolic lysophos-pholipase: Purification, characterization, and competitive inhibition by L-palmitoyl carnitine. J Biol Chem 258: 5221–5226, 1983PubMedGoogle Scholar
  17. 17.
    Gross R, Drisdel R, Sobel B: Rabbit myocardial lysophos-pholipase-transacylase: Purification, characterization, and inhibition by endogenous cardiac amphiphiles. J Biol Chem 258: 15165–15172, 1983PubMedGoogle Scholar
  18. 18.
    Wolf RA, Gross RW: Identification of neutral active phos-pholipase С which hydrolizes choline glycerophospholipids and plasmalogen selective phospholipase A2 in canine myocardium. J Biol Chem 260: 7295–7303, 1985PubMedGoogle Scholar
  19. 19.
    Gross R, Corr P, Lee B, Saffitz J, Crafford Jr W, Sobel B: Incorporation of radiolabeled lysophosphatidyl choline into canine Purkinje fibers and ventricular muscle: Electrophysiological, biochemical, and autoradiographic correlations. Circ Res 51: 27–36, 1982PubMedGoogle Scholar
  20. 20.
    Knabb M, Saffitz J, Corr P, Sobel B: The dependence of electrophysiological derangements on accumulation of endogenous long-chain acyl carnitine in hypoxic neonatal rat myocytes. Circ Res 58: 230–240, 1986PubMedGoogle Scholar
  21. 21.
    Fink K, Gross R: Modulation of canine myocardial sarco-lemmal membrane fluidity by amphiphilic compounds. Circ Res 55: 585–594, 1984PubMedGoogle Scholar
  22. 22.
    Gross R: High plasmalogen and arachidonic acid content of canine myocardial sarcolemma: A fast atom bombardment mass spectroscopic and gas chromatography-mass spectroscopic characterization. Biochemistry 23: 158–165, 1984PubMedCrossRefGoogle Scholar
  23. 23.
    Gross R: Identification of plasmalogen as the major phospholipid constituent of cardiac sarcoplasmic reticulum. Biochemistry 24: 1662–1668, 1985PubMedCrossRefGoogle Scholar
  24. 24.
    Wolf R, Gross R: Semi-synthetic approach for the preparation of homogeneous plasmenylethanolamine utilizing phospholipase D from Streptomyces Chromofuscus. J Lipid Res 26: 629–633, 1985PubMedGoogle Scholar
  25. 25.
    Pak J, Bork V, Norberg R, Creer M, Wolf R, Gross R: Disparate molecular dynamics of plasmenylcholine and phosphatidylcholine bilayers. Biochemistry 26: 4824–4830, 1987PubMedCrossRefGoogle Scholar
  26. 26.
    Lucchesi B, Mullane K: Leukocytes and ischemia-induced myocardial injury. Ann Rev Pharmacol Toxicol 26: 201–224, 1986CrossRefGoogle Scholar
  27. 27.
    Rowe G, Manson N, Caplan M, Hess M: Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmic reticulum: participation of the cyclooxygenase pathway. Circ Res 53: 584–591, 1983PubMedGoogle Scholar
  28. 28.
    Frimer A: Reaction of Singlet Oxygen with Olefins. Question of Mechanism. Chem Reviews 79: 359–386, 1979CrossRefGoogle Scholar
  29. 29.
    Kanofsky J, Hoogland H, We ver R, Weiss S: Singlet oxygen production by human eosinophils. J Biol Chem 263: 9692–9696, 1988PubMedGoogle Scholar
  30. 30.
    Corey E, Mehrotra M, Khan A: Antiarthritic gold compounds effectively quench electronically excited singlet oxygen. Science 236: 68–69, 1987PubMedCrossRefGoogle Scholar
  31. 31.
    Frimer A: In the chemistry of peroxides (Patai S, ed), pp 201–234, John Wiley & Sons, New York, 1983Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Linda A. Scherrer
    • 1
    • 2
  • Richard W. Gross
    • 1
    • 2
  1. 1.Department of MedicineWashington University Medical SchoolSt. LouisUSA
  2. 2.Department of ChemistryWashington University Medical SchoolSt. LouisUSA

Personalised recommendations